A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects

Clinical trial NCT05607693 · UNKNOWN

Trial details

NCT number: NCT05607693
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Castration-Resistant Prostate Cancer

Start date: 2023-04-26
Primary completion: 2024-11-05
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.